|4Feb 23, 4:05 PM ET

Goldwasser Benad 4

4 · Odysight.ai Inc. · Filed Feb 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Odysight.ai (ODYS) Director Goldwasser Receives Replacement Options

What Happened

  • Goldwasser Benad, a director of Odysight.ai Inc. (ODYS), was involved in a derivative exchange on February 19, 2026: the company cancelled 248,411 options and replaced them with 248,411 new options, and cancelled 69,796 options and replaced them with 69,796 new options — a total of 318,207 options replaced. No per-share price or total dollar value is reported in the Form 4 (derivative transactions are listed as N/A). This action reflects an extension/replacement of option terms rather than an open‑market purchase or sale of common stock.

Key Details

  • Transaction date: February 19, 2026; Form 4 filed February 23, 2026 (filed within the Section 16 reporting window).
  • Transaction types reported: Disposition to issuer (D) for cancellation of old options and Grant/Award (A) for issuance of replacement options (derivative transactions; prices reported as N/A).
  • Options affected: 248,411 (old → replacement) and 69,796 (old → replacement); total replaced = 318,207.
  • Shares/options owned after transaction: not specified in the filing.
  • Footnote: The Board approved a three-year extension of the term of the options, which resulted in cancellation of the “old” options and grant of “replacement” options (per filing footnote).
  • Filing timeliness: Reported within the required period (no late filing flag).

Context

  • This is an option-term extension/replacement, not a stock purchase or sale; it does not immediately change outstanding common shares or represent insider cashing out. Such restructurings are typically administrative (preserving option value or aligning terms) and do not necessarily signal the director’s view on the company’s near-term stock direction.

Insider Transaction Report

Form 4
Period: 2026-02-19
Transactions
  • Disposition to Issuer

    Options to purchase common stock (right to buy)

    [F1]
    2026-02-19248,4110 total
    Exercise: $2.61Exp: 2027-02-12Common Stock (248,411 underlying)
  • Award

    Options to purchase common stock (right to buy)

    [F1]
    2026-02-19+248,411248,411 total
    Exercise: $2.61Exp: 2030-02-12Common Stock (248,411 underlying)
  • Disposition to Issuer

    Options to purchase common stock (right to buy)

    [F1]
    2026-02-1969,7960 total
    Exercise: $2.61Exp: 2027-06-22Common Stock (69,796 underlying)
  • Award

    Options to purchase common stock (right to buy)

    [F1]
    2026-02-19+69,79669,796 total
    Exercise: $2.61Exp: 2030-06-22Common Stock (69,796 underlying)
Footnotes (1)
  • [F1]On February 19, 2026, the Board of Directors of the Company approved a three-year extension of the term of the options held by the reporting person, resulting in the cancellation of the "old" options and the grant of "replacement" options.
Signature
/s/ Benad Goldwasser|2026-02-23

Documents

1 file
  • 4
    ownership.xmlPrimary

    4